Caption Management’s Praxis Precision Medicines PRAX Stock Holding History

Caption Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,300	Closed	-$10.3M	–	1952
2025 Q4	$9.81M	Buy	33,300 +26,943	+424%	+$5.02M	0.07%	340
2025 Q3	$337K	Sell	6,357 -32,679	-84%	-$1.58M	﹤0.01%	1388
2025 Q2	$1.64M	Buy	39,036 +20,756	+114%	+$790K	0.02%	784
2025 Q1	$692K	Buy	+18,280	New	+$1.14M	0.01%	1010
2024 Q4	–	Sell	-9,204	Closed	-$666K	–	1756
2024 Q3	$530K	Buy	+9,204	New	+$497K	0.01%	918

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Caption Management's PRAX Position: Q1 2026 in Review

Caption Management sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 33,300 shares — an estimated $10.3M sold.

Caption Management first reported a position in PRAX in Q3 2024 and held it in 5 quarters. The position peaked at $9.81M in Q4 2025. 291 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

Caption Management reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
Caption Management sold 33,300 Praxis Precision Medicines shares in Q1 2026, an estimated $10.3M.
Caption Management first reported a position in Praxis Precision Medicines in Q3 2024 and held it in 5 quarters.
Caption Management's Praxis Precision Medicines position peaked at $9.81M in Q4 2025.
291 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.